Atricure Inc. buy UBS Group AG
Start price
30.04.25
/
50%
€29.29
Target price
30.04.26
€51.01
Performance (%)
-1.38%
Price
02.10.25
€28.89
Summary
This prediction is currently active. With a performance of -1.38%, the BUY prediction by UBS_Group_AG is trending in the wrong direction. This prediction currently runs until 30.04.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Atricure Inc. | -2.432% | -2.432% |
| iShares Core DAX® | 2.709% | 3.467% |
| iShares Nasdaq 100 | 0.867% | 5.198% |
| iShares Nikkei 225® | 3.135% | 9.423% |
| iShares S&P 500 | 0.886% | 3.586% |
Comments by UBS_Group_AG for this prediction
In the thread Atricure Inc. diskutieren
AtriCure, Inc. (NASDAQ: ATRC) had its price target lowered by analysts at UBS Group AG from $60.00 to $58.00. They now have a "buy" rating on the stock.
Ratings data for ATRC provided by MarketBeat